AstraZeneca and Global Transparency
Use a maximum of two downloads here
Home / Sustainability / Ethics and transparency / AstraZeneca and Global Transparency
Our Approach
AstraZeneca strongly believes that interactions with Health Care Providers (HCPs) and Healthcare Organisations (HCOs) positively influence the quality of patient treatment and the value of medical research.
To provide patients with optimal treatment options, HCPs need to stay informed about the latest developments with current and potential new medicines. The pharmaceutical industry has a duty to provide this information.
HCPs in turn provide the industry with insights into how to improve medicines by feeding back on how they work in real world settings.
We also recognize that patients expect transparency around these relationships to feel confident that HCPs are impartial and always recommend the most appropriate treatment options.
We believe that regulations such as US Open Payments, the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure code, and others across the globe, which require companies to disclose payments and transfers of value made to HCPs and HCOs, will provide greater transparency around these already well-regulated relationships.
Disclosure of Payments and Transfers
The payments and transfers of value disclosed here were made for activities such as providing professional advice about how medicines are used in practice, sharing professional expertise at medical education meetings, taking part in advisory boards, research and educational grants.
AstraZeneca Europe
To download the assumptions and interpretations of the EFPIA Code of Practice for each of our markets, and to download market-level disclosure reports, please click on the country links below.
The 2025 Self Certification Letter affirms AstraZeneca’s commitment to the principles of the EFPIA Code of Practice.
Austria
Belgium
2024
2023
2022
Bulgaria
2024
2023
2022
2021
2020
Croatia
2024
2023
2022
2021
2020
Cyprus
Transparency obligations have been fulfilled per local requirements. Disclosures can be found via the following link: http://kefea.org.cy/disclosure-new/
Czech Republic
2024
2023
2022
Denmark
Transparency obligations have been fulfilled per local requirements.
Disclosures can be found via the following link: https://laegemiddelstyrelsen.dk/da/godkendelse/tilknytning-og-oekonomisk-stoette,-for-fag-og-sundhedspersoner/offentliggjort-liste/liste-over-personer-der-modtager-oekonomisk-stoette-eller-har-tilknytning-til-virksomheder/
Estonia
2024
2023
2022
2021
2020
Finland
2024
2023
2022
2021
2020
France
Transparency obligations have been fulfilled per local requirements. Disclosures can be found via the following link: https://www.transparence.sante.gouv.fr/
Transparency obligations have also been fulfilled per EFPIA requirements as it relates to cross - border transfers of value. Disclosures can be found via the following links:
2024
2024 France EFPIA Disclosure Summary Report_French
2023
2023 France EFPIA Disclosure Summary report
2022
Germany
Transparency obligations have been fulfilled per local requirements.
Disclosure for Healthcare Professionals and Healthcare Organisations can be found via the following link: https://public-de.azpaymentdisclosureexternal.com/
Disclosure for Patient Organisations can be found via the following links: https://www.astrazeneca.de/nachhaltigkeit/transparenz-und-offenlegung.html and https://www.fsa-pharma.de/transparenzveroeffentlichungen/
Greece
2024
2023
2022
Hungary
2024
2023
2022
Iceland
Transparency obligations have been fulfilled per local requirements.
Disclosures can be found via the following link: https://frumtok.is/en/codes-and-ethics/dc-reports-for-2024-activities/
Ireland
Italy
2024
2023
2022
Latvia
Transparency obligations have been fulfilled per local requirements. Disclosures can be found via the following link:
https://www.vi.gov.lv/lv/pazinojums-par-biedribam-nodibinajumiem-un-arstniecibas-iestadem-sniegto-materialo-vai-cita-veida-atbalstu-2
Transparency obligations have also been fulfilled per EFPIA requirements. Disclosures can be found via the following links:
2024
2023
2022
2021
2020
Lithuania
Transparency obligations have been fulfilled per local requirements. Disclosures can be found via the following link: https://vvkt.lrv.lt/lt/veiklos-sritys/vaistu-reklamos-kontrole/perleistos-vertes/
Transparency obligations have also been fulfilled per EFPIA requirements. Disclosures can be found via the following links:
2024
2023
2022
2021
2020
Luxembourg
Malta
Netherlands
Transparency obligations have been fulfilled per local requirements. Disclosures can be found via the following link: https://www.transparantieregister.nl/home
Norway
2024
2023
2022
Poland
2024
2023
2022
2021
2020
Portugal
Transparency obligations have been fulfilled per local requirements.
Disclosures can be found via the following link: https://extranet.infarmed.pt/pmro/
Romania
Transparency obligations have been fulfilled per local requirements.
Disclosures of Sponsorships and Benefits can be found via the following link: https://sponsorizari.anm.ro/ and R&D spend https://arpim.ro/codul-de-etica/
Serbia
2024
2023
2022
2021
2020
Slovakia
Transparency obligations have been fulfilled per local requirements.
Disclosures can be found via the following link: https://www.nczisk.sk/Statisticke_vystupy/Zverejnovanie_podla_zakona_liekoch_zdravotnickych_pomockach/Sumarne_spravy_o_vydavkoch/Pages/default.aspx
Slovenia
2024
2023
2022
Spain
Transparency obligations have been fulfilled per local requirements.
Disclosures can be found via the following link: https://www.astrazeneca.es/nuestracompania/Transparencia.html
Sweden
2024
2023
2022
2021
2020
Switzerland
2024
2023
2022
2021
2020
Turkey
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
Ukraine
2024
2023
2022
2021
2020
United Kingdom
2024
Transparency obligations have been fulfilled per local requirements. HCO/HCP/ORDM disclosure can be found via the following link:
https://search.disclosureuk.org.uk/
Disclosure for Patient Organisations and the Public including Patients and Journalists can be found via the following link:
https://www.astrazeneca.co.uk/partnerships/working-with-patient-groups
Alexion Europe
Austria
2024
2023
2022
Finland
2024
2023
2022
Ireland
2024
2023
2022
Italy
2024
2023
2022
Norway
2024
2023
2022
Spain
2024
2023
Sweden
2024
2023
2022
Switzerland
2024
2023
2022
US
For information about US Open Payments, please visit our Physician engagement page or the US Open Payments page managed by the Centers for Medicaid and Medicare Services (CMS).
Alternatively, for information regarding other US specific disclosure activity, please visit the US Corporate Transparency page.
Astrazeneca Asia Pacific
Australia
HCP Payments and Transfers of Value Report
Sponsorship of Third Party Educational Events Report
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
Health Consumer Organisations Report
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
New Zealand
HCP and HCO Payments and Transfers of Value Report
Indonesia
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
Japan
Philippines
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
South Korea
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
Alexion Asia Pacific
Australia
HCP Payments and Transfers of Value Report
Sponsorship of Third Party Educational Events Report
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
Health Consumer Organisations Report
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
Latin America
Brazil State of Minas Gerais
2023
2022
2021
2020
2019
2018
Chile
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Colombia
2024
2023
2022
2021
2020
2019
Middle East & Africa
Israel
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
Saudi Arabia
Transparency obligations have been fulfilled per local requirements. Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.
Last updated October 2025